Public Profile

Embio

Embio, officially known as Embio Limited, is a pioneering biotechnology company headquartered in India. Established in 2013, Embio has rapidly positioned itself at the forefront of the biopharmaceutical industry, focusing on innovative solutions in drug development and bioprocessing. With a strong operational presence across major regions in India, the company has achieved significant milestones, including the development of unique biopharmaceutical products that cater to unmet medical needs. Embio's core offerings include advanced biopharmaceuticals and cutting-edge bioprocessing technologies, distinguished by their commitment to quality and efficacy. The company has garnered recognition for its contributions to the industry, establishing a reputation for excellence and innovation. As a key player in the biotechnology sector, Embio continues to drive advancements that enhance healthcare outcomes and improve patient lives.

DitchCarbon Score

How does Embio's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

0

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

Embio's score of 0 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.

1%

Embio's reported carbon emissions

As of the latest available data, Embio has not disclosed any specific carbon emissions figures or reduction targets. Without concrete emissions data, it is challenging to assess their current carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the absence of reported figures does not diminish the importance of climate commitments in the industry. Embio's approach to climate action may involve various initiatives aimed at reducing environmental impact, although specific details on reduction targets or climate pledges have not been provided. In the context of increasing global emphasis on sustainability, it is crucial for companies like Embio to establish clear and measurable climate commitments to align with industry standards and contribute to broader climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Embio's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Embio is headquartered in IN, which has a rank of very high, indicating very high grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Embio is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Home Service

GB
Health Services
Updated 10 days ago

Active Pharma Inc.

CA
Health Services
Updated 10 days ago

Surface Chemists

US
Health Services
Updated 10 days ago

Jones Healthcare

CA
Health Services
Updated 9 days ago

Nuzest

US
Health Services
Updated 10 days ago

Nova Scotia Limited

CA
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers